Ocular Therapeutix, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement
Article By: ChinaBio® Today
Saturday, September 23, 2023 2:19 PM EDT
Shanghai Everest Medicines acquired China/Asian rights to a novel therapy for autoimmune diseases from Kezar Life Sciences of South San Francisco in a deal worth $132.5 million. The company will make an upfront payment of $7 million to Kezar.
In this article: NVS, BGNE, KZR Also: BMY, OCUL
Read
Week In Review: CStone Out-Licenses Ex-China Rights To Two Immunotherapies In $1.3 Billion Deal
Article By: ChinaBio® Today
Saturday, October 31, 2020 1:05 PM EDT
CStone Pharma out-licensed global rights for two immunoncology assets to US-based EQRx in a $1.3 billion agreement. CStone will receive $150 million upfront and up to $1.15 billion in milestone payments, plus royalties.
In this article: PFE, CASI, INCY, OCUL, ZLAB
Read
2 Hot Biotechs With Major FDA Catalysts
Article By: TipRanks
Wednesday, October 24, 2018 4:58 AM EDT
Biotech stocks can soar or plunge depending on FDA decisions. There’s no doubt that buying ahead of PDUFA dates is a risky call.
In this article: ACRX, CPRX Also: TXMD, OCUL
Read
Morning Call For Wednesday, August 22
Article By: Jim Van Meerten
Wednesday, August 22, 2018 8:03 AM EDT
Sep E-mini S&Ps (ESU18 -0.16%) this morning are down -0.06% on concern about President Trump's legal woes after his former lawyer pleaded guilty to illegal campaign finance charges late Tuesday afternoon.
In this article: LZB, PSA, TGT, CSII, SMCI, GSM, JKHY, MYGN, RRGB, SCSC, URBN, PSTG, OCUL, KEYS
Read
Morning Call For Thursday, Jan. 25
Article By: Jim Van Meerten
Thursday, January 25, 2018 9:56 AM EDT
Mar E-mini S&Ps (ESH18 +0.30%) this morning are up +0.21% as commodity producers and energy stocks rally with the dollar index sliding further to a new 3-year low.
In this article: CLS, DG, DLB, F, LM, VAR, WHR, FFIV, LRCX, XLNX, ONCE, OCUL, SSTI, IOVA
Read
All Posts

Latest Tweets for $OCUL

No tweets yet!

PARTNER HEADLINES